Tapinarof has been shown by Smith et al. to induce expression of epidermal differentiation genes in keratinocytes and to improve inflammation in an AHR-dependent manner using both a human ex vivo air-liquid interface culture model and an imiquimod dermatitis mouse model (8). The gene discussed is AHR; the disease is skin disorder.